You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Alzheimer's disease patients show reduced cyclic adenosine monophosphate (cAMP) formation. This study links early adenylate cyclase activity decline to Alzheimer's progression, impacting potential drug treatments.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: